Intensity- and timing-dependent modulation of motion perception with transcranial magnetic stimulation of visual cortex.

Motion sensitive cortex TMS TMS Evoked potential Transcranial magnetic stimulation Visual evoked potential Visual motion

Journal

Neuropsychologia
ISSN: 1873-3514
Titre abrégé: Neuropsychologia
Pays: England
ID NLM: 0020713

Informations de publication

Date de publication:
10 2020
Historique:
received: 03 06 2020
revised: 23 07 2020
accepted: 04 08 2020
pubmed: 17 8 2020
medline: 25 6 2021
entrez: 16 8 2020
Statut: ppublish

Résumé

Despite the widespread use of transcranial magnetic stimulation (TMS) in research and clinical care, the dose-response relations and neurophysiological correlates of modulatory effects remain relatively unexplored. To fill this gap, we studied modulation of visual processing as a function of TMS parameters. Our approach combined electroencephalography (EEG) with application of single pulse TMS to visual cortex as participants performed a motion perception task. During each participants' first visit, motion coherence thresholds, 64-channel visual evoked potentials (VEPs), and TMS resting motor thresholds (RMT) were measured. In second and third visits, single pulse TMS was delivered at one of two latencies, either 30 ms before the onset of motion or at the onset latency of the N2 VEP component derived from the first session. TMS was delivered at 0%, 80%, 100%, or 120% of RMT over the site of N2 peak activity, or at 120% over vertex. Behavioral results demonstrated a significant main effect of TMS timing on accuracy, with better performance when TMS was applied at the N2-Onset timing versus Pre-Onset, as well as a significant interaction, indicating that 80% intensity produced higher accuracy than other conditions at the N2-Onset. TMS effects on the P3 VEP showed reduced amplitudes in the 80% Pre-Onset condition, an increase for the 120% N2-Onset condition, and monotonic amplitude scaling with stimulation intensity. The N2 component was not affected by TMS. These findings reveal the influence of TMS intensity and timing on visual perception and electrophysiological responses, with optimal facilitation at stimulation intensities below RMT.

Identifiants

pubmed: 32795456
pii: S0028-3932(20)30254-2
doi: 10.1016/j.neuropsychologia.2020.107581
pmc: PMC7554219
mid: NIHMS1622789
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

107581

Subventions

Organisme : NIMH NIH HHS
ID : RF1 MH114253
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

Ann Neurol. 2005 Oct;58(4):553-60
pubmed: 16178033
Hum Brain Mapp. 2009 Apr;30(4):1387-96
pubmed: 18537115
Cereb Cortex. 2005 Nov;15(11):1736-41
pubmed: 15703247
Neuropsychologia. 2016 Apr;84:193-7
pubmed: 26916969
Neurosci Biobehav Rev. 2014 Sep;45:295-304
pubmed: 25010557
Neurol Res. 2002 Apr;24(3):266-70
pubmed: 11958420
J Neurosci. 2015 Apr 1;35(13):5351-9
pubmed: 25834059
J Neurosci. 2008 Nov 12;28(46):12071-84
pubmed: 19005072
PLoS One. 2010 Apr 22;5(4):e10281
pubmed: 20421968
Neurosci Lett. 2004 Nov 23;371(2-3):111-6
pubmed: 15519739
Brain Stimul. 2019 Jul - Aug;12(4):1051-1054
pubmed: 30962028
Science. 2001 Apr 20;292(5516):510-2
pubmed: 11313497
Hum Brain Mapp. 2008 Jun;29(6):662-70
pubmed: 17598167
Cereb Cortex. 2015 Apr;25(4):1052-9
pubmed: 24152544
J Neurosci. 2011 Mar 2;31(9):3290-4
pubmed: 21368040
Electroencephalogr Clin Neurophysiol. 1989 Nov-Dec;74(6):458-62
pubmed: 2480226
Vision Res. 2007 Jan;47(2):189-202
pubmed: 17129593
Neurosci Biobehav Rev. 2019 Dec;107:47-58
pubmed: 31473301
Exp Brain Res. 2017 Jan;235(1):205-217
pubmed: 27683006
Vision Res. 1997 Jul;37(13):1845-9
pubmed: 9274769
Neurosci Lett. 2020 Jun 21;730:135022
pubmed: 32413540
Trends Neurosci. 2016 Nov;39(11):782-795
pubmed: 27697295
Clin Neurophysiol. 2004 Apr;115(4):812-9
pubmed: 15003761
Neuroimage. 2005 Feb 15;24(4):955-60
pubmed: 15670672
Clin Neurophysiol. 2014 Nov;125(11):2247-2252
pubmed: 24725846
Physiol Res. 2002;51(2):199-204
pubmed: 12108931
Brain. 1995 Feb;118 ( Pt 1):49-60
pubmed: 7895014
Physiol Res. 1998;47(4):265-70
pubmed: 9803473
Brain Stimul. 2018 Sep - Oct;11(5):1189-1191
pubmed: 29885859
Biol Psychol. 1982 Feb-Mar;14(1-2):1-52
pubmed: 6809064
Neuropsychologia. 2010 Oct;48(12):3563-72
pubmed: 20713072
J Cogn Neurosci. 2018 Oct;30(10):1517-1531
pubmed: 29916788
Neuroimage. 2014 Nov 1;101:425-39
pubmed: 25067813
Neuroscience. 2017 Nov 5;363:134-141
pubmed: 28893648
Neurosci Biobehav Rev. 2011 Jan;35(3):516-36
pubmed: 20599555
J Neurophysiol. 2007 Sep;98(3):1253-62
pubmed: 17634339
Front Hum Neurosci. 2020 Jan 24;14:4
pubmed: 32038206
Annu Rev Biomed Eng. 2007;9:527-65
pubmed: 17444810
Psychophysiology. 2001 May;38(3):557-77
pubmed: 11352145
Exp Brain Res. 2001 Oct;140(4):397-406
pubmed: 11685392
Clin Neurophysiol. 2009 Dec;120(12):2008-2039
pubmed: 19833552
Phys Rev Lett. 2000 Mar 13;84(11):2310-3
pubmed: 11018872
Clin Neurophysiol. 2002 Sep;113(9):1501-4
pubmed: 12169333
Eur J Neurosci. 2007 Mar;25(6):1874-81
pubmed: 17408427
Cereb Cortex. 2002 Jun;12(6):663-9
pubmed: 12003865
Proc Biol Sci. 1992 Aug 22;249(1325):173-8
pubmed: 1360678
Neuroimage. 2019 Jan 15;185:300-312
pubmed: 30347282
J ECT. 2006 Sep;22(3):169-75
pubmed: 16957531
Front Psychol. 2018 May 17;9:741
pubmed: 29867693
Percept Psychophys. 1990 Dec;48(6):603-17
pubmed: 2270192
Clin Neurophysiol. 2017 Nov;128(11):2125-2139
pubmed: 28938143
Brain Stimul. 2015 Nov-Dec;8(6):1175-82
pubmed: 26169802
Clin Neurophysiol. 2006 Aug;117(8):1699-707
pubmed: 16797232
Clin Neurophysiol. 1999 Aug;110(8):1325-8
pubmed: 10454266
Neuroimage. 2006 Feb 15;29(4):1326-35
pubmed: 16185899
Clin Neurophysiol. 2004 Mar;115(3):583-8
pubmed: 15036054
J Neurophysiol. 1995 Sep;74(3):1037-45
pubmed: 7500130
Spat Vis. 1997;10(4):433-6
pubmed: 9176952
Brain Topogr. 2015 May;28(3):520-8
pubmed: 23996091
J Neurosci Methods. 2018 Jan 15;294:34-39
pubmed: 29103999
J Neurosci. 2011 Mar 2;31(9):3143-7
pubmed: 21368025
Neuroreport. 2004 Feb 9;15(2):297-302
pubmed: 15076756
Neuroreport. 2008 Sep 17;19(14):1423-7
pubmed: 18766024

Auteurs

Olga Lucia Gamboa Arana (OL)

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, USA.

Hannah Palmer (H)

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, USA.

Moritz Dannhauer (M)

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, USA.

Connor Hile (C)

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, USA.

Sicong Liu (S)

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, USA.

Rena Hamdan (R)

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, USA.

Alexandra Brito (A)

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, USA.

Roberto Cabeza (R)

Department of Psychology & Neuroscience, Duke University, USA; Center for Cognitive Neuroscience, Duke University, USA.

Simon W Davis (SW)

Center for Cognitive Neuroscience, Duke University, USA; Department of Neurology, Duke University School of Medicine, USA.

Angel V Peterchev (AV)

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, USA; Department of Biomedical Engineering, Duke University, USA; Department of Electrical & Computer Engineering, Duke University, USA; Department of Neurosurgery, Duke University School of Medicine, USA.

Marc A Sommer (MA)

Department of Psychology & Neuroscience, Duke University, USA; Center for Cognitive Neuroscience, Duke University, USA; Department of Biomedical Engineering, Duke University, USA; Department of Neurobiology, Duke University School of Medicine, USA.

Lawrence G Appelbaum (LG)

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, USA; Center for Cognitive Neuroscience, Duke University, USA. Electronic address: greg@duke.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH